Articles tagged with Covid 19
Researchers at Gwangju Institute of Science and Technology (GIST) have developed a deep learning-based biosensing platform called DeepGT, which can accurately quantify nanoscale bioparticles, including viruses. The platform harnesses the advantages of Gires-Tournois biosensors and AI to refine visual artifacts and extract relevant info...
Researchers will study the spread of SARS-CoV-2 among deer, including captive and wild populations, as well as its relationship with humans and the environment. The project aims to understand disease ecology in whole systems and inform better management practices for deer producers.
Researchers at Cold Spring Harbor Laboratory discovered that bat genomes contain unique adaptations to defend against infection and cancer. The study highlights the interconnectedness of immunity and cancer response, revealing potential new treatments for human diseases.
Patients with long COVID exhibit reduced serotonin levels, leading to inflammation and neurological symptoms. Treating serotonin deficiencies may reverse memory impairment in small animal models.
A recent VA study analyzed electronic health records of over 5.9 million veterans to provide insights into COVID-19 mortality rates. The research found that absolute numbers of deaths were higher in younger age groups and healthier individuals, despite older adults experiencing the highest rate of excess mortality.
A study of 222 US hospitals found that 79.4% of patient-facing websites did not mention abortion, with limited information provided when it was mentioned. This lack of disclosure may contribute to stigma surrounding abortion care.
A recent study published in CHEST Science Journal reveals that high-performance ICUs exhibited lower mortality rates during the COVID-19 pandemic, with a range of 3.6% to 63.2%. The research also found that these ICUs had better patient outcomes before and after the pandemic, regardless of disease severity or comorbidities.
A primary mRNA vaccine series offers significant protection against SARS-CoV-2 infection in Singaporean children aged 1-4. The study found a low incidence of hospitalization and severe illness, but highlights the potential benefits of vaccination in preventing infection and sequelae.
Scientists have discovered the open and closed states of the coronavirus E ion channel, which could help develop antiviral drugs to reduce inflammation. The study's findings provide insights into the channel's structure and function, allowing researchers to design molecules that can bind to it and prevent inflammation.
Research found that young children's immune systems produce protective antibodies at high levels for up to 300 days after infection. Unlike adults, children have high levels of inflammatory cytokines in their noses but not in their blood, potentially explaining the mildness of COVID-19 in this age group.
A study by the Complexity Science Hub analyzed work discourse on Reddit between 2018 and 2021, finding that mental health concerns significantly contributed to the surge in quit rates. The study suggests that companies can improve working conditions by prioritizing employees' relational and self-fulfillment needs.
Researchers discovered that young children's immune systems produce fewer and more stable antibodies against SARS-CoV-2, which may explain why they rarely develop severe cases of the virus. This unique response is characterized by narrow-spectrum antibodies effective against the original variant but less protective against other variants.
A study found that daily mindfulness training at home reduced kids' stress levels and negative emotions, while a remote, app-based intervention showed improvements in mental health. Researchers suggest that mindfulness can support mental well-being and promote mental health in diverse children.
A new AI tool named EVEscape can predict future viral variants of concern, potentially helping scientists develop more effective vaccines and therapies. The tool uses evolutionary and biological information to forecast which mutations will occur in viruses like SARS-CoV-2.
A large population-level study found that patients with mental health conditions experienced fewer disruptions in care after the transition to virtual psychotherapy, with a shorter time between appointments. Individuals with depressive, anxiety, or bipolar disorders were more likely to maintain consistent visits.
A cross-sectional study found that most survey respondents who gave birth between June and December 2020 did not use prenatal telehealth. Personal preference for in-person care was the most common reason among those who chose not to use telehealth services.
A new AI tool developed by Brazilian researchers can detect potentially cancerous lung nodules in CT reports, missing a crucial early diagnosis. The NLP tool achieved an accuracy rate of 97% in identifying suspicious nodules.
A Singaporean study found that unvaccinated COVID-19 survivors are at a heightened risk of heart complications almost a year after recovery. The study revealed a 56% higher risk of developing new heart complications among unvaccinated survivors compared to uninfected individuals.
A retrospective cohort study found COVID-19 substantially increases risk for autoimmune and autoinflammatory connective tissue disorders. Long-term management of COVID-19 patients should include evaluation for these disorders.
A multicenter clinical trial found that high-dose inhaled nitric oxide improved oxygenation and reduced the risk of sensory and motor neurologic symptoms in adults with severe COVID-19 pneumonia. The treatment was also linked to lower levels of SARS-CoV-2 in the blood and sputum.
Post-Acute Sequelae of COVID-19 research aims to track long-term health symptoms in survivors. A $3.7 million grant will support the development of self-supervised deep learning technologies to recognize post-COVID lung progression phenotypes.
Researchers have developed a human vascular organoid model that accurately mimics the damage caused by SARS-CoV-2, revealing clues for a potential COVID-19 treatment. The study identified a long-acting monoclonal antibody targeting factor D as a promising approach to mitigate severe vascular damage and thrombosis associated with COVID-19.
A new study reveals that immunity to SARS-CoV-2 variants depends on previous exposure and vaccination history. The research found significant differences in immune responses to various variants, highlighting the need for personalized vaccine approaches.
A new study published in AJIC found that enhanced pandemic-related infection prevention and control measures significantly decreased healthcare-associated infections, including C. difficile, CLABSI, and RVIs. The findings suggest prioritizing evidence-based IPC practices can reduce HAIs even among vulnerable populations during extreme ...
A Dartmouth-led study found that tweets featuring K-pop group BTS generated 111 times more virality than similar tweets without the artist's name. This highlights the power of entertainment in driving public health messages and bridging cultural divides.
Researchers at Utrecht University have uncovered a sophisticated mechanism by which coronavirus spike proteins can be activated for cell entry. Sugar binding induces opening of the spike protein and exposure of the receptor binding domain, required for subsequent entry steps.
A new study using wastewater surveillance has predicted the start of the annual RSV season 12 days early, allowing hospitals to prepare and allocate resources effectively. The study used real-time wastewater measurements to forecast the surge in pediatric RSV cases, providing a population-level early warning signal for the community.
The Australian Long COVID services lack several categories, including early investigation, accessibility, and trustworthy public health information. Researchers propose building a response on US and UK guidelines that prioritize early detection, mental health support, and referral to multidisciplinary clinics.
Researchers have identified a crucial host protein, SND1, that plays a key role in SARS-CoV-2 replication. The virus uses its own protein NSP9 as a primer for RNA synthesis, which is facilitated by SND1 binding to negative-sense viral RNA.
A substantial burden of RSV-associated hospitalizations was found in Canadian pediatric hospitals, especially among infants under six months. The study suggests that preventive strategies for these young infants could lead to decreased RSV disease burden in children.
During the pandemic, New Yorkers increased their participation in wild and backyard food activities such as gardening, hunting, and foraging. Despite a general worsening of diets, these activities may have contributed to buffering those effects, with people consuming home-produced eggs and meat, and backyard-grown fruits and vegetables.
Research published in European Journal of Neurology indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity. Among participants who reported worsening migraines, those infected were 2.5-times more likely to be concerned about migraine worsening than those vaccinated.
Researchers have developed a synthetic peptide that could help reduce vascular problems associated with acute respiratory distress syndrome in COVID-19. The peptide, called TIP, works by binding to a subunit of the epithelial sodium channel, which helps maintain barrier function and prevent damage from viral proteins.
A new study reveals that independent physician practices experienced a smaller drop in patient volume than their larger counterparts during the height of the COVID-19 pandemic. This finding suggests that independent practices can thrive and provide quality care to patients with chronic conditions.
Researchers found that antigen testing significantly reduces the probability of cluster occurrence by identifying and isolating infected persons. However, it may not be effective against highly infectious mutant strains like Omicron, highlighting the need for booster vaccination campaigns and other infection control measures.
The study found an increase in eating disorder emergency department visits and hospitalizations among females aged 10-17, 18-26, 27-40, and 41-105 years during the COVID-19 pandemic. Risk factors such as isolation, social media use, and decreased access to care may have contributed to this surge.
A new study found that nearly 40% of eligible adults did not receive a COVID-19 booster due to prior infection with SARS-CoV-2 or concerns about vaccine side effects. The researchers hope the findings can inform design of interventions to improve vaccination rates.
A study by Osaka University found that belief in just deserts (BJD) was highest in Japan and lowest in the UK, while human rights restriction (HRR) was highest in China and lowest in Japan. The research suggests that BJD and HRR are positively correlated in some countries, leading to increased disease-related prejudice and discrimination.
The study found that Paxlovid treatment was associated with reduced risk of COVID-19 hospitalization or death in clinically extremely vulnerable individuals. Severely immunocompromised patients showed the greatest benefit from this treatment.
Scientists have developed a trivalent vaccine candidate that provides broad and long-lasting protection against COVID-19 infection by delivering the vaccine via the nose. The vaccine triggers a strong neutralizing antibody response and protects mucosal areas, preventing disease symptoms.
NTU Singapore's study found social media fatigue hampers cognitive judgment, leading to misinformation acceptance. Narcissistic individuals experiencing fatigue are more likely to share misinformation, regardless of accuracy.
A 50-state survey study found a strong association between COVID-19 misinformation and the use of non-evidence-based treatments like ivermectin and hydroxychloroquine. The study suggests that misinformation may lead to increased harm from ineffective and potentially toxic treatments.
Researchers are investigating gastrointestinal symptoms, specifically irritable bowel syndrome, as a condition of long COVID using a $3.2 million grant. The study aims to better evaluate and treat COVID-19-related IBS by analyzing data from the Arizona CoVHORT research study.
A recent study published in JAMA Network Open reveals that viral pathogens, particularly SARS-CoV-2, are a significant contributor to sepsis. The researchers found that approximately 1 in 6 cases of sepsis were associated with SARS-CoV-2 infections during the COVID-19 pandemic.
Using data from Mass General Brigham’s electronic health records, researchers found that SARS-CoV-2 accounted for approximately 1 in 6 cases of sepsis during the COVID-19 pandemic. The mortality rate for patients with SARS-CoV-2-associated sepsis was initially high but declined over time.
A study of 431,000 inpatient encounters found SARS-CoV-2–associated sepsis had higher mortality than presumed bacterial sepsis. Electronic health record-based algorithms demonstrated utility for viral and bacterial sepsis surveillance.
A study found that reduced mobility during the pandemic led to greater risk for depressive symptoms, even after controlling for local COVID-19 activity and other factors. The research suggests that increasing social engagement and limiting social isolation may be crucial for mitigating mental health impacts during future pandemics.
A new study reveals that COVID-19 triggers a dangerous immune response in hardened fatty deposits lining the heart's largest blood vessels. This inflammation can lead to immediate and longer-lasting heart issues, including plaque rupture and blockage of blood flow.
An observational study of nearly 70,000 COVID-19 patients found that Paxlovid lowered risk of death by 84% and Legevrio by 77%, reducing combined risk of hospitalization and death by over 40%. The treatments were effective across all patient subgroups and against newer Omicron subvariants.
Researchers found SARS-CoV-2 directly infects coronary arteries, causing fatty plaque to become inflamed. The virus replicates in macrophages, leading to increased inflammation and potentially worsening cardiovascular complications.
A new study finds that US state and territory COVID-19 websites do not meet accessibility standards, making it difficult for visually impaired individuals to access critical health information. The researchers identified a range of accessibility problems, including incompatibility with screen readers and limited contrast.
The article discusses the need to reassess COVID-19 precautions in 2023, particularly for patients with hematologic malignancies. The researchers highlight the increased risk of poor response to vaccination and worse outcomes from COVID-19 infection among these patients.
Researchers identified two SARS-CoV-2 protein mutations linked to severe COVID-19 symptoms and increased inflammation. The mutations, known as KR, were found in patients with higher viral loads and more severe symptoms.
Researchers at the University of Surrey have developed an electronic diagnostic test for bacteria and viruses, including SARS-CoV-2. The 'Electro-chemical LAMP' (eLAMP) test is affordable, sensitive, and can be performed at home or in a hospital lab.
University of Liverpool researchers develop a new material that captures coronavirus particles with minimal impact on breathability, increasing efficiency by approximately 93%. The new material has the potential to be used in various applications, including face masks and air filters.
Researchers at Yale School of Medicine identified distinct immune and hormonal responses in people with long COVID, which may help scientists develop new diagnostics and therapies. The study found increased circulation of antibodies that fight non-COVID-19 viruses and lower levels of cortisol, a steroid hormone released during stress.
Researchers identified specific blood biomarkers that can accurately identify patients with long COVID, revealing distinct immune and hormone function differences. The study also found abnormal T cell activity, reactivation of latent viruses, and reduced cortisol levels in patients with long COVID.
Researchers have found a link between the antiviral drug molnupiravir and a pattern of mutations in the SARS-CoV-2 virus. The study used global sequencing databases to map mutations over time, identifying a mutational signature associated with individuals who took molnupiravir.
A new machine-learning model, PLABAC, predicts coronavirus disease progression in hospitalized patients based on five routine tests and patient age. The model has shown strong results in predicting mortality for patients with COVID-19 variants, offering improved outcomes for patients hospitalized with the virus.
A study using engineered mice found that BA.5, a contagious omicron subvariant, replicates rapidly early during infection, causing significant weight loss and high levels of inflammatory cells and cytokines in lungs.